ADVB advanbiomed.com: Margin resik

Advanced Biomed - logo grafis emiten ADVB

Advanced Biomed Inc (ADVB) generates revenue from supplying liquid biopsy systems to clinics and hospitals. The net margin structure confirms financial stability, with the current figure standing at -6325.90. The company develops microfluidic platforms featuring AI-driven cell analysis for early screening. Business growth is driven by the successful commercialization of developments and the progress of clinical trials, rendering the asset independent of macroeconomic fluctuations.

advanbiomed.com (ADVB) - Rentabilitas dodolan miturut bathi resik saka 07.03.2025 nganti 19.11.2026

Rincian metrik komprehensif lan analitis Advanced Biomed Inc. (ADVB)

- rega saham lan prakiraan rega para ahli:
- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:Advanced Biomed Inc - ADVB
Barang unggulan Advanced Biomed

The integration of ESG principles and the greening of biochemical processes at Advanced Biomed Inc (ADVB) directly impact the operational expenditure structure. The consolidated net profit margin reflects the portion of net income in every dollar of revenue after deducting all expenses. The compression of this metric on the chart signals that costs are outstripping revenues. A positive trend confirms the efficiency of resource management. This current price action determines the stability of the asset's market value.

Pesaing langsung

ONC: Margin dodolan resik|Margin resik Halozyme Inc. (HALO)|Margin resik RevMed|Rentabilitas dodolan resik AAPG (Ascentage Pharma Group)|Margin dodolan resik CGON|UroGen Pharma - Rentabilitas dodolan resik|Bicara Therapeutics - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Personalis Inc PSNL|Erasca Oncology - Margin dodolan resik|Tingkat bathi resik DCTH (Delcath Corp)|YMAB: Margin dodolan resik|AURA - Margin dodolan perusahaan|CADL (Candel Therapeutics Inc.) - Margin dodolan resik|Rentabilitas dodolan resik ARAY (Accuray)|Rentabilitas dodolan miturut bathi resik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Margin resik|Margin resik Citius Oncology, Inc. CTOR|HURA - Rentabilitas dodolan miturut bathi resik|protaratx.com - Margin dodolan resik|FATE - Margin dodolan resik|WHWK: Margin dodolan resik|TScan Therapeutics (TCRX) - Margin dodolan resik|Margin resik Champions Oncology|Margin resik XBIT|Margin dodolan resik CVM|Rentabilitas dodolan miturut bathi resik OS Therapies Inc. OSTX|Margin resik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Margin resik|ANL - Margin resik|Margin resik verupharma.com|TPST: Margin dodolan resik|XLO - Margin dodolan perusahaan|Margin resik Renovaro|Margin dodolan resik muraloncology.com|Margin dodolan resik KAPA|Margin dodolan perusahaan OnKure Therapeutics, Inc.|Margin dodolan resik GDTC (w2.cytomed.sg)|CRIS - Rentabilitas dodolan miturut bathi resik|Apollomics - Margin dodolan resik|Tharimmune Corp (THAR) - Rentabilitas dodolan miturut bathi resik|GNPX: Margin dodolan resik|CLDI (Calidi Biotherapeutics Inc.) - Margin resik|Margin resik Sunshine Biopharma, Inc.|Margin dodolan resik xeneticbio.com|Margin resik Salarius (SLRX)|Rentabilitas dodolan miturut bathi resik Purple Biotech PPBT|Margin resik American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Margin resik|Checkpoint Therapeutics Inc. - Margin dodolan resik|Tingkat bathi resik ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Rentabilitas dodolan miturut bathi resik|Ikena Oncology, Inc. - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik NTBL|VIRX: Tingkat bathi resik|Margin resik MorphoSys Corporation (MOR)|NAYA - Margin resik|Margin dodolan resik AAPGV (Ascentage)